|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02315 BIOCYTOGEN-B
Nominal 
5.840 0.000 (0.000%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 |
| Property, plant, equip. & others | 1,450,828 | -9.271% | 1,599,079 | 1,390,945 | 1,135,591 |
| Land & other Lease Assets | 0 | -- | 0 | 0 | 0 |
| Intangible Assets | 28,130 | -8.228% | 30,652 | 6,055 | 2,428 |
| Interests in Asso. & JCEs | 188,375 | -4.834% | 197,944 | 9,685 | 10,087 |
| Other Non-current Assets | 59,025 | 11.661% | 52,861 | 21,860 | 30,774 |
| 1,726,358 | -8.199% | 1,880,536 | 1,428,545 | 1,178,880 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 7,416 | -60.138% | 18,604 | 15,140 | 7,980 | |
| Trade Receivables | 142,384 | 32.226% | 107,682 | 103,089 | 67,226 | |
| Cash & Bank Balances | 399,607 | -34.585% | 610,882 | 466,445 | 750,044 | |
| Other Current Assets | 173,643 | -4.659% | 182,128 | 289,564 | 322,388 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | |
| 723,050 | -21.347% | 919,296 | 874,238 | 1,147,638 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 175,234 | 19.867% | 146,190 | 102,441 | 87,599 | ||
| S-T Debt & Leases | 203,199 | 18.412% | 171,603 | 26,897 | 14,106 | ||
| Other Current Liabilities | 199,183 | -30.900% | 288,253 | 317,221 | 226,760 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | ||
| 577,616 | -4.691% | 606,046 | 446,559 | 328,465 | |||
| Net Current Assets | 145,434 | -53.573% | 313,250 | 427,679 | 819,173 | ||
| Total Assets Less Current Liabilities | 1,871,792 | -14.678% | 2,193,786 | 1,856,224 | 1,998,053 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 340,910 | 39.902% | 243,677 | 62,902 | 66,812 | |||
| Other Non-current Liabilities | 740,446 | -7.362% | 799,293 | 541,351 | 473,000 | |||
| 1,081,356 | 3.680% | 1,042,970 | 604,253 | 539,812 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 399,398 | 0.000% | 399,398 | 374,930 | 360,000 | ||||
| Reserves | 386,488 | -48.252% | 746,867 | 872,278 | 1,093,411 | ||||
| Others | 0 | -- | 0 | 0 | 0 | ||||
| Shareholders' Funds | 785,886 | -31.439% | 1,146,265 | 1,247,208 | 1,453,411 | ||||
| Non-controlling Interests | 4,550 | -0.022% | 4,551 | 4,763 | 4,830 | ||||
| Others | 0 | -- | 0 | 0 | 0 | ||||
| 790,436 | -31.315% | 1,150,816 | 1,251,971 | 1,458,241 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | 12,458 | 40.959% | 8,838 | 52,575 | 262,905 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 02/12/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -50,673,000 |
| %Change | -73.303% |
| EPS / (LPS) | RMB -0.130 |
| NBV Per Share (¥) | RMB 1.852 |